Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Levine

Showing results (731-740 of 799) with videos related to

Pageof 80
Sort By:
Neurology|May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study GroupS C Fagan, L B Morgenstern, A Petitta, et al.
JAMA Surgery|January 27, 2021
Effect of a Predictive Model on Planned Surgical Duration Accuracy, Patient Wait Time, and Use of Presurgical Resources: A Randomized Clinical TrialChristopher T Strömblad, Ryan G Baxter-King, Amirhossein Meisami, et al.
Journal of the American Heart Association|June 23, 2020
Depression and Psychosocial Stress Are Associated With Subclinical Carotid Atherosclerosis Among Women Living With HIVMatthew E Levy, Kathryn Anastos, Steven R Levine, et al.
JAMA|June 6, 2024
Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical TrialGbenga Ogedegbe, Jeanne A Teresi, Stephen K Williams, et al.
JAMA|February 6, 2004
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic strokeSteven R Levine, Robin L Brey, Barbara C Tilley, et al.
Stroke (Hoboken, N.J.)|January 23, 2026
DWI Positivity in Mild, Nondisabling Acute Cerebral Ischemia: Data From the PRISMS TrialLily L Wang, Pooja Khatri, Shyam Prabhakaran, et al.
Stroke|August 6, 2015
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke TrialOpeolu Adeoye, Heidi Sucharew, Jane Khoury, et al.
Blood Cancer Journal|July 26, 2012
Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasmsK L Rice, X Lin, K Wolniak, et al.
Leukemia|March 30, 2013
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cellsY Wei, R Chen, S Dimicoli, et al.
Nature Chemical Biology|October 16, 2024
Methylarginine targeting chimeras for lysosomal degradation of intracellular proteinsLaurence J Seabrook, Carolina N Franco, Cody A Loy, et al.
Pageof 80

Showing results (731-740 of 799) with videos related to

Sort By:
Pageof 80
Neurology|May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study GroupS C Fagan, L B Morgenstern, A Petitta, et al.
JAMA Surgery|January 27, 2021
Effect of a Predictive Model on Planned Surgical Duration Accuracy, Patient Wait Time, and Use of Presurgical Resources: A Randomized Clinical TrialChristopher T Strömblad, Ryan G Baxter-King, Amirhossein Meisami, et al.
Journal of the American Heart Association|June 23, 2020
Depression and Psychosocial Stress Are Associated With Subclinical Carotid Atherosclerosis Among Women Living With HIVMatthew E Levy, Kathryn Anastos, Steven R Levine, et al.
JAMA|June 6, 2024
Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical TrialGbenga Ogedegbe, Jeanne A Teresi, Stephen K Williams, et al.
JAMA|February 6, 2004
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic strokeSteven R Levine, Robin L Brey, Barbara C Tilley, et al.
Stroke (Hoboken, N.J.)|January 23, 2026
DWI Positivity in Mild, Nondisabling Acute Cerebral Ischemia: Data From the PRISMS TrialLily L Wang, Pooja Khatri, Shyam Prabhakaran, et al.
Stroke|August 6, 2015
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke TrialOpeolu Adeoye, Heidi Sucharew, Jane Khoury, et al.
Blood Cancer Journal|July 26, 2012
Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasmsK L Rice, X Lin, K Wolniak, et al.
Leukemia|March 30, 2013
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cellsY Wei, R Chen, S Dimicoli, et al.
Nature Chemical Biology|October 16, 2024
Methylarginine targeting chimeras for lysosomal degradation of intracellular proteinsLaurence J Seabrook, Carolina N Franco, Cody A Loy, et al.
Pageof 80